Approval · Notice of Compliance 10338 · 2009
SUTENT: Notice of Compliance 10338
Issued July 7, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10338
- Date
- July 7, 2009
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 37.5 mg capsules
- Therapeutic class
- Tyrosine Kinase Inhibitor / Anti-Tumour Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUTENT | 02328607 | Cancelled Pre Market |
Medicinal ingredients
- SUNITINIB MALATE 37.5 MG per CAP